Gatik is revolutionizing B2B delivery and logistics with its proprietary Level 4 autonomous technology, Gatik Carrier™, designed for the middle mile. The company optimizes supply chains by transporting goods between distribution centers, fulfillment centers, and retail locations without the need for human drivers. Gatik's Autonomous Transportation as a Service (ATaaS) model enhances reliability, reduces costs, and increases sustainability for its clients. With a focus on known, repeatable routes and a commitment to safety, Gatik is positioned as a leader in the autonomous logistics space, having established partnerships with major companies like Walmart and Tyson Foods, and expanding operations across North America.
Ixana is a pioneering company in the field of high-speed human-computer interaction, specializing in the development of the Wi-R silicon chip, which enables efficient communication between wearable devices. Their technology significantly reduces energy consumption and latency compared to traditional wireless methods like Bluetooth and Wi-Fi, making it ideal for applications in smart devices and wearables. With a focus on creating a seamless user experience, Ixana aims to transform how devices communicate by confining signals to the user's body, thus enhancing security and efficiency. The company has garnered attention for its innovative approach and has received accolades such as the Startup of the Year Mira Award, positioning it as a leader in the wearable technology market.
Horizon3.ai is a global leader in autonomous security solutions, specializing in the Node Zero platform, which provides comprehensive penetration testing services. The platform enables organizations to conduct internal, external, and cloud pentesting, ensuring continuous security assessments across various attack surfaces. With a focus on automating vulnerability detection and remediation, Node Zero empowers security teams to proactively identify and address potential threats, enhancing their overall security posture. The company has gained recognition in the cybersecurity industry, being named to the 2025 Fortune Cyber 60, and serves a diverse clientele, including large organizations and managed security service providers (MSSPs).
ANELLO Photonics is a pioneering technology company specializing in silicon photonics and inertial navigation sensors. Their flagship product, the Si Ph OG™, is a groundbreaking optical gyroscope that offers high-performance navigation solutions at a lower cost, making it suitable for various applications including robotics, defense, and autonomous vehicles. The company aims to democratize access to high-quality navigation sensors, addressing the growing demand in GPS-denied environments. With a strong focus on innovation and a robust patent portfolio, ANELLO is well-positioned in the rapidly expanding autonomous navigation market.
Rogo is an innovative Ag-Tech company specializing in robotic soil sampling services that provide farmers with accurate and accountable data for efficient fertilizer application. Their unique technology utilizes RTK-level GPS and a self-driving robot to ensure precise sampling at true depths and exact locations, significantly reducing errors compared to traditional methods. With a strong market presence and a reported 95% grower adoption rate within a year, Rogo is positioned to scale its operations from 300K acres to 5M acres, making it a compelling investment opportunity in the precision agriculture sector.
ClearBlade is an Edge Computing software company enabling enterprises to rapidly engineer and run secure, real-time, scalable IoT applications. ClearBlade was built for the enterprise from the ground up to run securely in any cloud, on-premise, and at the edge. ClearBlade enables companies to ingest, analyze, adapt and act on any data in real time and at an extreme scale. Users can unleash their data by leveraging local computing, artificial intelligence, and actionable visualizations while integrating with any enterprise system - all from a single platform. The industry-leading ClearBlade Edge delivers the full power of the ClearBlade Platform directly to devices and gateways. The ClearBlade Edge runs autonomously - independent of network connectivity - ensuring resiliency and security. ClearBlade’s patented communications-agnostic AutoSync technology guarantees your environment is always up-to-date. ClearBlade is fully extensible with a suite of proven components and integrations to deliver solutions quickly and at scale. ClearBlade empowers you to focus on business results and outcomes. Providing a consistent platform across edge, cloud, and on-premise environments. ClearBlade is headquartered in Austin, TX.
Karyosoft is a Hudson Alpha backed, fast-growing no-code genomics software and data science start-up that empowers life scientists to manage and transform genomics data efficiently. Their products, including Variants, Loci, and Variant Mining Studio, provide automated solutions for SNP and Indel calling, data management, and visualization, significantly reducing the time required for genomic analysis. Karyosoft aims to simplify complex data management and analytics, positioning itself as a leader in the agri-genomics sector, with a mission to accelerate innovations in plant, animal, and human health.
Novilytic is a molecular recognition company that utilizes patented nanotechnology to monitor the quality of lifesaving medicines in real-time. Their flagship product, the Proteometer, allows pharmaceutical companies to conduct at-line batch analysis every 10 minutes, significantly reducing the time and cost associated with traditional quality control methods that can take hours to days. This innovative approach not only enhances product safety but also enables real-time product release, thereby improving efficiency in drug development and manufacturing. With partnerships with major pharmaceutical companies and a strong intellectual property portfolio, Novilytic is positioned to disrupt the pharmaceutical industry by making life-saving drugs more accessible and affordable.
Rhea Space Activity (RSA) is focused on applying advanced and disruptive technology to create a secure lunar and deep space environment for the U.S. and allied nations. The company integrates existing deep space technology with cutting-edge research to develop reliable navigation and secure communication technologies, positioning itself as a key player in the space technology sector. RSA's innovative approach and commitment to national security objectives differentiate it in the market, aiming to revolutionize cislunar technology and enhance operational capabilities in space.
Fiber X is a pioneering company focused on transforming corn stover, the agricultural residue left after corn harvest, into high-value, sustainable materials. By leveraging innovative upcycling technology and strong partnerships with local farmers, Fiber X aims to reduce reliance on petroleum in the chemicals and materials industries. Their proprietary processes create eco-friendly additives and products that enhance performance while supporting environmental stewardship. With a commitment to quality and sustainability, Fiber X is positioned to revolutionize the use of biomass, benefiting both the economy and the environment.
On Target Laboratories is a biotechnology start-up focused on developing targeted intraoperative molecular imaging agents that help surgeons detect and remove cancerous tissues more effectively during surgery. Their flagship product, Cytalux, is FDA-approved for use in ovarian and lung cancer, enhancing surgical outcomes by illuminating cancerous lesions in real-time. Founded in 2010, the company leverages pioneering research from Purdue University to advance cancer imaging technology, aiming to improve patient outcomes and reduce the likelihood of residual cancer post-surgery. With a commitment to innovation and compassion, On Target Laboratories is positioned to make significant impacts in the oncology field.
Umoja Biopharma is a biopharmaceutical company focused on developing innovative CAR T-cell therapies that reprogram the immune system in vivo to target and eliminate cancer cells. Their integrated platform therapeutics are designed to treat solid tumors and hematological cancers that are resistant to existing treatments, positioning them at the forefront of cancer immunotherapy. With a commitment to advancing the future of immunotherapy, Umoja aims to extend the benefits of their therapies to every patient in need, leveraging a world-class team of experts and a robust pipeline of treatments.